Nanotechnology Now - Press Release: "Bruker BioSciences Corporation to Present at Annual NanoEquity Europe 2007 Conference in Frankfurt"

Home > Press > Bruker BioSciences Corporation to Present at Annual NanoEquity Europe 2007 Conference in Frankfurt

Dr. Frank Burgaezy (Photo: Business Wire)

Dr. Frank Burgaezy (Photo: Business Wire)

Abstract:
Bruker BioSciences Corporation today announced that it is joining other companies involved with nanotechnology in presenting this week at the Annual NanoEquity Europe Conference. This event, organized by the Deutsche Boerse Group, takes place June 11th and 12th, 2007 in Frankfurt am Main, Germany at the Hilton Hotel. Bruker AXS Executive Vice President Dr. Frank Burgaezy will present an overview of the Company, including a briefing on Bruker's activities in the nanotechnology arena. In 2006, more than 500 participants took the opportunity to meet representatives from science on the one hand and company decision makers and capital market players on the other.

Bruker BioSciences Corporation to Present at Annual NanoEquity Europe 2007 Conference in Frankfurt

BILLERICA, MA | Posted on June 11th, 2007

Using Bruker's cutting-edge NANOSTAR and D8 DISCOVER X-ray analyzers, materials scientists and engineers of today are able to understand and influence the properties of materials on a nanoscale level. The development of exciting new materials such as designer polymers and bioceramics and continuing advances with materials such as liquid crystals, metal-organic and thin film coatings are made possible by investigating and altering their nanostructures. Bruker's NANOSTAR makes use of SAXS (Small-Angle X-ray Scattering), a reliable and non-destructive method for analyzing nanostructured materials yielding information such as particle sizes and size distributions as well as shape and orientation distributions in liquid, powders and bulk samples. The D8 DISCOVER is the leading analyzer for XRD (X-ray Diffraction) and XRR (X-ray Reflectometry) with a large range of applications including the examination of the molecular structure and the characterization of thin films and multilayers.

Regarding Bruker's mass spectrometry business, Bruker Daltonics Inc. and Nanosys Inc. recently announced their entry into a broad R&D collaboration and distribution agreement for Nanosys' nanotechnology-enabled matrix-free target plates for use primarily with Bruker's FLEX(TM)-series of laser desorption ionization (LDI) time-of-flight (TOF) mass spectrometers. These Nanosys plates are known as Capture and Analyze (CA) NALDI(TM) chips.

Dr. Burgaezy is scheduled to present at 11:25 AM Central European Time on Tuesday.

####

About Bruker BioSciences Corporation
Bruker BioSciences Corporation in Billerica, Massachusetts, is the publicly traded parent company of Bruker Daltonics Inc., Bruker AXS Inc. and Bruker Optics Inc.

For more information, please click here

Contacts:
Bruker BioSciences Corporation
Michael Willett, +1 978-663-3660, ext. 1411
Investor Relations and Public Relations Officer

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark: